Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
112,550
Sort by:
Complex Regional Pain Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF COMPLEX REGIONAL PAIN SYNDROME PIPELINE REPORT INCLUDES Panorama of Complex Regional Pain Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Complex Regional Pain Syndrome Pipeline candidates across ...
August 2018
30 pages
Constipation R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF CONSTIPATION PIPELINE REPORT INCLUDES Panorama of Constipation pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
90 pages
Contact Dermatitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CONTACT DERMATITIS PIPELINE REPORT INCLUDES Panorama of Contact Dermatitis pipeline markets including statistics on therapeutic drugs and companies involved Contact Dermatitis Pipeline candidates across various development ...
August 2018
40 pages
Contrast Induced Nephropathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CONTRAST INDUCED NEPHROPATHY PIPELINE REPORT INCLUDES Panorama of Contrast Induced Nephropathy pipeline markets including statistics on therapeutic drugs and companies involved Contrast Induced Nephropathy Pipeline candidates across various development ...
August 2018
30 pages
Corneal Neovascularization R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CORNEAL NEOVASCULARIZATION PIPELINE REPORT INCLUDES Panorama of Corneal Neovascularization pipeline markets including statistics on therapeutic drugs and companies involved Corneal Neovascularization Pipeline candidates across various development ...
August 2018
20 pages
Coronary Artery Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CORONARY ARTERY DISEASE PIPELINE REPORT INCLUDES Panorama of Coronary Artery Disease pipeline markets including statistics on therapeutic drugs and companies involved Coronary Artery Disease Pipeline candidates across various development ...
August 2018
160 pages
Coronaviridae Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CORONAVIRIDAE INFECTIONS PIPELINE REPORT INCLUDES Panorama of Coronaviridae Infections pipeline markets including statistics on therapeutic drugs and companies involved Coronaviridae Infections Pipeline candidates across various development ...
August 2018
80 pages
Crigler Najjar Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CRIGLER NAJJAR SYNDROME PIPELINE REPORT INCLUDES Panorama of Crigler Najjar Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Crigler Najjar Syndrome Pipeline candidates across various development ...
August 2018
30 pages
Critical Limb Ischemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CRITICAL LIMB ISCHEMIA PIPELINE REPORT INCLUDES Panorama of Critical Limb Ischemia pipeline markets including statistics on therapeutic drugs and companies involved Critical Limb Ischemia Pipeline candidates across various development ...
August 2018
110 pages
Cryptococcosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF CRYPTOCOCCOSIS PIPELINE REPORT INCLUDES Panorama of Cryptococcosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
20 pages
Cryptosporidiosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF CRYPTOSPORIDIOSIS PIPELINE REPORT INCLUDES Panorama of Cryptosporidiosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Cushing's Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CUSHING'S SYNDROME PIPELINE REPORT INCLUDES Panorama of Cushing's Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Cushing's Syndrome Pipeline candidates across various development ...
August 2018
50 pages
Cytomegalovirus Infection (HHV 5) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF CYTOMEGALOVIRUS INFECTION (HHV 5) PIPELINE REPORT INCLUDES Panorama of Cytomegalovirus Infection (HHV 5) pipeline markets including statistics on therapeutic drugs and companies involved Cytomegalovirus Infection (HHV 5) Pipeline candidates across ...
August 2018
140 pages
Deep Vein Thrombosis (DVT) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF DEEP VEIN THROMBOSIS (DVT) PIPELINE REPORT INCLUDES Panorama of Deep Vein Thrombosis (DVT) pipeline markets including statistics on therapeutic drugs and companies involved Deep Vein Thrombosis (DVT) Pipeline candidates across ...
August 2018
30 pages
Degenerative Disc Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF DEGENERATIVE DISC DISEASE PIPELINE REPORT INCLUDES Panorama of Degenerative Disc Disease pipeline markets including statistics on therapeutic drugs and companies involved Degenerative Disc Disease Pipeline candidates across various development ...
August 2018
50 pages
Dengue Fever R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF DENGUE FEVER PIPELINE REPORT INCLUDES Panorama of Dengue Fever pipeline markets including statistics on therapeutic drugs and companies involved Dengue Fever Pipeline candidates across various development ...
August 2018
130 pages
Dental Pain R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF DENTAL PAIN PIPELINE REPORT INCLUDES Panorama of Dental Pain pipeline markets including statistics on therapeutic drugs and companies involved Dental Pain Pipeline candidates across various development ...
August 2018
30 pages
Dermatomycoses R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF DERMATOMYCOSES PIPELINE REPORT INCLUDES Panorama of Dermatomycoses pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Dermatomyositis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF DERMATOMYOSITIS PIPELINE REPORT INCLUDES Panorama of Dermatomyositis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
160 pages
Diabetic Foot Ulcers R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF DIABETIC FOOT ULCERS PIPELINE REPORT INCLUDES Panorama of Diabetic Foot Ulcers pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Foot Ulcers Pipeline candidates across various development ...
August 2018
110 pages
Diabetic Gastroparesis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF DIABETIC GASTROPARESIS PIPELINE REPORT INCLUDES Panorama of Diabetic Gastroparesis pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Gastroparesis Pipeline candidates across various development ...
August 2018
50 pages
Diabetic Neuropathic Pain R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF DIABETIC NEUROPATHIC PAIN PIPELINE REPORT INCLUDES Panorama of Diabetic Neuropathic Pain pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Neuropathic Pain Pipeline candidates across various development ...
August 2018
80 pages
Diabetic Neuropathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF DIABETIC NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Diabetic Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Neuropathy Pipeline candidates across various development ...
August 2018
80 pages
Diabetic Peripheral Neuropathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF DIABETIC PERIPHERAL NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Diabetic Peripheral Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Peripheral Neuropathy Pipeline candidates across various development ...
August 2018
60 pages
Diarrhea R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF DIARRHEA PIPELINE REPORT INCLUDES Panorama of Diarrhea pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
120 pages
Dilated Cardiomyopathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF DILATED CARDIOMYOPATHY PIPELINE REPORT INCLUDES Panorama of Dilated Cardiomyopathy pipeline markets including statistics on therapeutic drugs and companies involved Dilated Cardiomyopathy Pipeline candidates across various development ...
August 2018
50 pages
Diphtheria R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF DIPHTHERIA PIPELINE REPORT INCLUDES Panorama of Diphtheria pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Down Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF DOWN SYNDROME PIPELINE REPORT INCLUDES Panorama of Down Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Down Syndrome Pipeline candidates across various development ...
August 2018
50 pages
Dravet Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF DRAVET SYNDROME PIPELINE REPORT INCLUDES Panorama of Dravet Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Dravet Syndrome Pipeline candidates across various development ...
August 2018
60 pages
Drug Addiction R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... ready to use format. SCOPE OF DRUG ADDICTION PIPELINE REPORT INCLUDES Panorama of Drug Addiction pipeline markets including statistics on therapeutic drugs and companies involved Drug Addiction Pipeline candidates across various development ...
August 2018
130 pages
Dupuytren Contracture R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF DUPUYTREN CONTRACTURE PIPELINE REPORT INCLUDES Panorama of Dupuytren Contracture pipeline markets including statistics on therapeutic drugs and companies involved Dupuytren Contracture Pipeline candidates across various development ...
August 2018
20 pages
Dyskinesia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF DYSKINESIA PIPELINE REPORT INCLUDES Panorama of Dyskinesia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
130 pages
Dystonia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF DYSTONIA PIPELINE REPORT INCLUDES Panorama of Dystonia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Eastern Equine Encephalitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF EASTERN EQUINE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Eastern Equine Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Eastern Equine Encephalitis Pipeline candidates across various development ...
August 2018
30 pages
Emphysema R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF EMPHYSEMA PIPELINE REPORT INCLUDES Panorama of Emphysema pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Encephalitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Encephalomyelitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ENCEPHALOMYELITIS PIPELINE REPORT INCLUDES Panorama of Encephalomyelitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Encephalopathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ENCEPHALOPATHY PIPELINE REPORT INCLUDES Panorama of Encephalopathy pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
End Stage Renal Disease (ESRD) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF END STAGE RENAL DISEASE (ESRD) PIPELINE REPORT INCLUDES Panorama of End Stage Renal Disease (ESRD) pipeline markets including statistics on therapeutic drugs and companies involved End Stage Renal Disease (ESRD) Pipeline candidates across ...
August 2018
40 pages
Endometriosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ENDOMETRIOSIS PIPELINE REPORT INCLUDES Panorama of Endometriosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
110 pages
Enterocolitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ENTEROCOLITIS PIPELINE REPORT INCLUDES Panorama of Enterocolitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Eosinophilic Esophagitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF EOSINOPHILIC ESOPHAGITIS PIPELINE REPORT INCLUDES Panorama of Eosinophilic Esophagitis pipeline markets including statistics on therapeutic drugs and companies involved Eosinophilic Esophagitis Pipeline candidates across various development ...
August 2018
50 pages
Ependymoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF EPENDYMOMA PIPELINE REPORT INCLUDES Panorama of Ependymoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
120 pages
Epidermolysis Bullosa R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF EPIDERMOLYSIS BULLOSA PIPELINE REPORT INCLUDES Panorama of Epidermolysis Bullosa pipeline markets including statistics on therapeutic drugs and companies involved Epidermolysis Bullosa Pipeline candidates across various development ...
August 2018
90 pages
Epstein Barr Viral Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF EPSTEIN BARR VIRAL INFECTIONS PIPELINE REPORT INCLUDES Panorama of Epstein Barr Viral Infections pipeline markets including statistics on therapeutic drugs and companies involved Epstein Barr Viral Infections Pipeline candidates across ...
August 2018
140 pages
Epstein–Barr Virus (HHV 4) Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF EPSTEIN–BARR VIRUS (HHV 4) INFECTIONS PIPELINE REPORT INCLUDES Panorama of Epstein–Barr Virus (HHV 4) Infections pipeline markets including statistics on therapeutic drugs and companies involved Epstein–Barr Virus (HHV 4) Infections Pipeline candidates across ...
August 2018
140 pages
Equine Encephalitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF EQUINE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Equine Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Equine Encephalitis Pipeline candidates across various development ...
August 2018
40 pages
Erectile Dysfunction R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ERECTILE DYSFUNCTION PIPELINE REPORT INCLUDES Panorama of Erectile Dysfunction pipeline markets including statistics on therapeutic drugs and companies involved Erectile Dysfunction Pipeline candidates across various development ...
August 2018
90 pages
Escherichia coli Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ESCHERICHIA COLI INFECTIONS PIPELINE REPORT INCLUDES Panorama of Escherichia coli Infections pipeline markets including statistics on therapeutic drugs and companies involved Escherichia coli Infections Pipeline candidates across various development ...
August 2018
150 pages
Essential Thrombocythemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ESSENTIAL THROMBOCYTHEMIA PIPELINE REPORT INCLUDES Panorama of Essential Thrombocythemia pipeline markets including statistics on therapeutic drugs and companies involved Essential Thrombocythemia Pipeline candidates across various development ...
August 2018
70 pages
